drugset / Trial / NCT02998541

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

NCT02998541 ↗

Phase 3 Terminated 219 enrolled Shire
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if an investigational treatment is effective compared with placebo and PVP-Iodine in the treatment of adults and children with adenoviral conjunctivitis.

Timeline

Start
2017-03-27
Primary completion
2019-05-13
Completion
2019-05-13

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision, unrelated to safety”

Drugs

EvaluationDrugModalityDoseRoute
Comparator PVP-I Unknown 0.6 % Other
Subject SHP640 Unknown 0.1 % Other
Subject SHP640 Unknown 0.6 % Other

Indications